Follow
Lisa Wang
Lisa Wang
Princess Margaret Cancer Center
Verified email at uhnresearch.ca
Title
Cited by
Cited by
Year
Potential drug interactions and duplicate prescriptions among cancer patients
RP Riechelmann, IF Tannock, L Wang, ED Saad, NA Taback, ...
Journal of the National Cancer Institute 99 (8), 592-600, 2007
3882007
A retrospective study assessing the incidence, risk factors and comorbidities of pamidronate-related necrosis of the jaws in multiple myeloma patients
F Jadu, L Lee, M Pharoah, D Reece, L Wang
Annals of Oncology 18 (12), 2015-2019, 2007
2152007
Molecular profiling of advanced solid tumors and patient outcomes with genotype-matched clinical trials: the Princess Margaret IMPACT/COMPACT trial
TL Stockley, AM Oza, HK Berman, NB Leighl, JJ Knox, FA Shepherd, ...
Genome medicine 8 (1), 1-12, 2016
2022016
Evolution of the randomized controlled trial in oncology over three decades
CM Booth, DW Cescon, L Wang, IF Tannock, MK Krzyzanowska
Journal of Clinical Oncology 26 (33), 5458, 2008
1492008
Expression analysis of 6p22 genomic gain in retinoblastoma
M Orlic, CE Spencer, L Wang, BL Gallie
Genes, Chromosomes and Cancer 45 (1), 72-82, 2006
1482006
Potential drug interactions in cancer patients receiving supportive care exclusively
RP Riechelmann, C Zimmermann, SN Chin, L Wang, A O'Carroll, ...
Journal of pain and symptom management 35 (5), 535-543, 2008
1442008
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of …
AJ Templeton, FE Vera-Badillo, L Wang, M Attalla, P De Gouveia, ...
Annals of oncology 24 (12), 2972-2977, 2013
1342013
Phase II trial of the histone deacetylase inhibitor belinostat in women with platinum resistant epithelial ovarian cancer and micropapillary (LMP) ovarian tumours
HJ Mackay, H Hirte, T Colgan, A Covens, K MacAlpine, P Grenci, L Wang, ...
European Journal of Cancer 46 (9), 1573-1579, 2010
1312010
A phase II study of sunitinib in recurrent and/or metastatic adenoid cystic carcinoma (ACC) of the salivary glands: current progress and challenges in evaluating molecularly …
NG Chau, SJ Hotte, EX Chen, SF Chin, S Turner, L Wang, LL Siu
Annals of oncology 23 (6), 1562-1570, 2012
1292012
Hyperprogressive disease in early‐phase immunotherapy trials: clinical predictors and association with immune‐related toxicities
Y Kanjanapan, D Day, L Wang, H Al‐Sawaihey, E Abbas, A Namini, ...
Cancer 125 (8), 1341-1349, 2019
1182019
Association of ipilimumab with safety and antitumor activity in women with metastatic or recurrent human papillomavirus–related cervical carcinoma
S Lheureux, MO Butler, B Clarke, MC Cristea, LP Martin, K Tonkin, ...
JAMA oncology 4 (7), e173776-e173776, 2018
1082018
Reporting of serious adverse drug reactions of targeted anticancer agents in pivotal phase III clinical trials
B Seruga, L Sterling, L Wang, IF Tannock
Journal of clinical oncology 29 (2), 174-185, 2011
1072011
A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: final results of a PMH, Chicago and California consortia trial
HW Hirte, L Vidal, GF Fleming, AK Sugimoto, RJ Morgan, JJ Biagi, ...
Journal of Clinical Oncology 26 (15_suppl), 5521-5521, 2008
1052008
Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's LymphomasPhase I Study of Decitabine and Vorinostat
A Stathis, SJ Hotte, EX Chen, HW Hirte, AM Oza, P Moretto, S Webster, ...
Clinical Cancer Research 17 (6), 1582-1590, 2011
1042011
The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell …
NG Chau, B Perez-Ordonez, K Zhang, NA Pham, J Ho, T Zhang, ...
Head & neck oncology 3 (1), 1-11, 2011
1032011
A phase II trial of sorafenib in first-line metastatic urothelial cancer: a study of the PMH Phase II Consortium
SS Sridhar, E Winquist, A Eisen, SJ Hotte, E McWhirter, IF Tannock, ...
Investigational new drugs 29 (5), 1045-1049, 2011
972011
Phase II clinical trial of adoptive cell therapy for patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and low-dose interleukin-2
LT Nguyen, SD Saibil, V Sotov, MX Le, L Khoja, D Ghazarian, L Bonilla, ...
Cancer Immunology, Immunotherapy 68 (5), 773-785, 2019
952019
Phase II clinical and pharmacokinetic study of aflibercept in patients with previously treated metastatic colorectal cancer
PA Tang, SJ Cohen, C Kollmannsberger, G Bjarnason, K Virik, ...
Clinical Cancer Research 18 (21), 6023-6031, 2012
892012
Cognitive functioning after radiotherapy or chemoradiotherapy for head-and-neck cancer
HK Gan, LJ Bernstein, J Brown, J Ringash, M Vakilha, L Wang, ...
International Journal of Radiation Oncology* Biology* Physics 81 (1), 126-134, 2011
852011
Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma
M Velec, CR Haddad, T Craig, L Wang, P Lindsay, J Brierley, A Brade, ...
International Journal of Radiation Oncology* Biology* Physics 97 (5), 939-946, 2017
802017
The system can't perform the operation now. Try again later.
Articles 1–20